{
    "nct_id": "NCT06121453",
    "official_title": "P50 Supplement: Improving Medications Adherence Equitably Among Patients With Metastatic Breast Cancer and Cardiovascular Disease",
    "inclusion_criteria": "* Women or men age >18 years\n* Diagnosed with stage IV/metastatic breast cancer prescribed endocrine therapy and a CDK4/6i\n* Prescribed at least 1 antihypertensive or statin medication for CVD prevention or treatment\n* Self-report of at least some nonadherence ET/CDK4/6i or CVD medication on nonadherence screener or verbally to a treating clinician, or nonadherent to ET, CDK4/6i, and/or CVD medication on pharmacy fill data in the EHR (proportion of days covered over prior 180 days <80%).\nHealthy volunteers allowed\nMust have minimum age of 18 Years\nMust have maximum age of 99 Years",
    "exclusion_criteria": "* Non-English or Non-Spanish speaking\n* Not cognitively able to complete study requirements\n* Inability to provide informed consent for any other reason (e.g, severe psychiatric illness, active substance use)\n* Unavailable for 28 weeks of follow-up",
    "miscellaneous_criteria": ""
}